{
    "clinical_study": {
        "@rank": "4829", 
        "arm_group": {
            "arm_group_label": "VIGADEXA", 
            "arm_group_type": "Experimental", 
            "description": "Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution, 1 drop instilled in the study eye 2 days before surgery, followed by 1 drop instilled 4 times a day the day before surgery. On the day of surgery, 1 drop was instilled 60 minutes prior to the procedure."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study was to determine the moxifloxacin aqueous penetration when dosing\n      with a combination drug Vigadexa preoperatively in cataract patients."
        }, 
        "brief_title": "Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa\u00ae in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution, 1 drop instilled in the study eye 2 days before surgery, followed by 1 drop instilled 4 times a day the day before surgery. On the day of surgery, 1 drop was instilled 60 minutes prior to the procedure.", 
                        "title": "VIGADEXA"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "35"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "10.4", 
                                            "@value": "71.2"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "21"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "14"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "This reporting group includes all enrolled subjects who received all doses of the test product."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Sponsor reserves the right of prior review of any publication or presentation of information related to the study."
            }, 
            "outcome_list": {
                "outcome": {
                    "description": "A 0.150 milliliter sample of the aqueous humor was obtained during cataract surgery. The concentration of moxifloxacin was measured by a validated procedure using high performance liquid-spectrometry.", 
                    "group_list": {
                        "group": {
                            "@group_id": "O1", 
                            "description": "Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution, 1 drop instilled in the study eye 2 days before surgery, followed by 1 drop instilled 4 times a day the day before surgery. On the day of surgery, 1 drop was instilled 60 minutes prior to the procedure.", 
                            "title": "VIGADEXA"
                        }
                    }, 
                    "measure_list": {
                        "measure": [
                            {
                                "category_list": {
                                    "category": {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "O1", 
                                                "@value": "31"
                                            }
                                        }
                                    }
                                }, 
                                "param": "Number", 
                                "title": "Number of Participants", 
                                "units": "participants"
                            }, 
                            {
                                "category_list": {
                                    "category": {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "O1", 
                                                "@lower_limit": "857.5", 
                                                "@upper_limit": "1363.7", 
                                                "@value": "1110.6"
                                            }
                                        }
                                    }
                                }, 
                                "description": "A 0.150 milliliter sample of the aqueous humor was obtained during cataract surgery. The concentration of moxifloxacin was measured by a validated procedure using high performance liquid-spectrometry.", 
                                "dispersion": "95% Confidence Interval", 
                                "param": "Mean", 
                                "title": "Mean Aqueous Humor Concentration of Moxifloxacin", 
                                "units": "nanograms per milliliter"
                            }
                        ]
                    }, 
                    "population": "Per protocol:  All subjects who met inclusion/exclusion criteria, received all doses of the test product, and underwent cataract surgery with aqueous humor sampling.", 
                    "safety_issue": "No", 
                    "time_frame": "Day 3 (operative day)", 
                    "title": "Mean Aqueous Humor Concentration of Moxifloxacin", 
                    "type": "Primary"
                }
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution, 1 drop instilled in the study eye 2 days before surgery, followed by 1 drop instilled 4 times a day the day before surgery. On the day of surgery, 1 drop was instilled 60 minutes prior to the procedure.", 
                        "title": "VIGADEXA"
                    }
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "3", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Protocol deviation"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "2", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Adverse Event"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "36", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "31", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "5", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "This reporting group includes all enrolled subjects.", 
                "recruitment_details": "Subjects were recruited from one study center in Brazil."
            }, 
            "point_of_contact": {
                "email": "alcon.medinfo@alcon.com", 
                "name_or_title": "Abayomi Ogundele, Global Medical Affairs Brand Lead", 
                "organization": "Alcon Research, Ltd.", 
                "phone": "1-888-451-3937"
            }, 
            "reported_events": {
                "desc": "Adverse events were obtained as solicited comments from the study subjects and as observations by the study Investigator as outlined in the study protocol.", 
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution, 1 drop instilled in the study eye 2 days before surgery, followed by 1 drop instilled 4 times a day the day before surgery. On the day of surgery, 1 drop was instilled 60 minutes prior to the procedure.", 
                        "title": "VIGADEXA"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "36"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "36"
                                        }, 
                                        "sub_title": "Hypertensive Crisis"
                                    }
                                }, 
                                "title": "Cardiac disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "frequency_threshold": "5"
                }, 
                "time_frame": "Adverse events were collected for the duration of the study. An adverse event was defined as any untoward medical occurrence, or deterioration of a pre-existing medical condition, that occurred during or after test product administration."
            }
        }, 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Cataract", 
        "condition_browse": {
            "mesh_term": "Cataract"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Requires cataract surgery;\n\n          -  Acceptable health status (medical history, physical, laboratory and ophthalmologic\n             exams);\n\n          -  Able to follow instructions and willing to attend all study visits;\n\n          -  Other protocol-defined inclusion criteria may apply.\n\n        Exclusion Criteria:\n\n          -  Any known or suspected allergies/hypersensitivity to any of the investigational test\n             product components;\n\n          -  History of invasive intraocular surgery in the eye to be operated, within 4 months\n             before enrollment;\n\n          -  Use of medications, as specified in protocol;\n\n          -  Severe dry eye syndrome;\n\n          -  Use of contact lenses two days before surgery until the last visit;\n\n          -  External eye disease, infection or inflammation of the eyes or eyelids;\n\n          -  Excessive bleeding tendency;\n\n          -  No vision in the eye not included in the study;\n\n          -  Pregnant or breastfeeding;\n\n          -  Other protocol-defined exclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "firstreceived_results_date": "June 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01859702", 
            "org_study_id": "RDG-11-235"
        }, 
        "intervention": {
            "arm_group_label": "VIGADEXA", 
            "intervention_name": "Moxifloxacin 0.5%/Dexamethasone 0.1% ophthalmic solution", 
            "intervention_type": "Drug", 
            "other_name": "Vigadexa\u00ae"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular", 
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate", 
                "BB 1101", 
                "Moxifloxacin", 
                "Norgestimate, ethinyl estradiol drug combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Aqueous Humor", 
            "Moxifloxacin", 
            "Vigadexa"
        ], 
        "lastchanged_date": "June 6, 2013", 
        "number_of_arms": "1", 
        "official_title": "Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa\u00ae in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients", 
        "overall_official": [
            {
                "affiliation": "Alcon Research", 
                "last_name": "Abayomi Ogundele, PharmD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Federal University of S\u00e3o Paulo, Ophthalmology Service", 
                "last_name": "Mauro Silveira de Queiroz Campos, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Brazil: Ethics Committee", 
                "Brazil: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "A 0.150 milliliter sample of the aqueous humor was obtained during cataract surgery. The concentration of moxifloxacin was measured by a validated procedure using high performance liquid-spectrometry.", 
            "measure": "Mean Aqueous Humor Concentration of Moxifloxacin", 
            "safety_issue": "No", 
            "time_frame": "Day 3 (operative day)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01859702"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Alcon Research", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Alcon Research", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}